Literature DB >> 7996554

Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation.

C Medana1, G Ermondi, R Fruttero, A Di Stilo, C Ferretti, A Gasco.   

Abstract

4-Phenyl-3-furoxancarbonitrile (2) affords nitric oxide under the action of thiol cofactors. Two principal products were isolated in the reaction with thiophenol: the phenylcyanoglyoxime (6) and 5-amino-3-phenyl-4-(phenylthio)isoxazole (7). Mechanisms which could account for the formation of these two products are discussed. Compound 2 is an efficient activator of the rat lung soluble guanylate cyclase, displays high vasodilatory activity on strips of rat thoracic aorta precontracted with noradrenaline, and is a potent inhibitor of platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996554     DOI: 10.1021/jm00051a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  28 in total

1.  Furoxans (1,2,5-oxadiazole-N-oxides) as novel NO mimetic neuroprotective and procognitive agents.

Authors:  Isaac T Schiefer; Lawren VandeVrede; Mauro Fa'; Ottavio Arancio; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2012-03-30       Impact factor: 7.446

2.  Characterization of inhibitors of glucocorticoid receptor nuclear translocation: a model of cytoplasmic dynein-mediated cargo transport.

Authors:  Hikmat N Daghestani; Guangyu Zhu; Paul A Johnston; Sunita N Shinde; Jeffrey L Brodsky; Billy W Day
Journal:  Assay Drug Dev Technol       Date:  2011-09-15       Impact factor: 1.738

3.  In Vitro Metabolic Stability and in Vivo Biodistribution of 3-Methyl-4-furoxancarbaldehyde Using PET Imaging in Rats.

Authors:  Adam B Pippin; Zaira Hidayah Mohd Arshad; Ronald J Voll; Jonathon A Nye; Sussan Ghassabian; Craig M Williams; Alessandra Mancini; Dennis C Liotta; Maree T Smith; Mark M Goodman
Journal:  ACS Med Chem Lett       Date:  2016-03-30       Impact factor: 4.345

4.  Studies on agents with mixed NO-dependent and calcium channel antagonistic vasodilating activities.

Authors:  C Cena; S Visentin; A Di Stilo; D Boschi; R Fruttero; A Gasco
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

5.  Synthesis and evaluation of resveratrol derivatives as fetal hemoglobin inducers.

Authors:  Priscila Longhin Bosquesi; Aylime Castanho Bolognesi Melchior; Aline Renata Pavan; Carolina Lanaro; Cristiane Maria de Souza; Radda Rusinova; Rafael Consolin Chelucci; Karina Pereira Barbieri; Guilherme Felipe Dos Santos Fernandes; Iracilda Zepone Carlos; Olaf Sparre Andersen; Fernando Ferreira Costa; Jean Leandro Dos Santos
Journal:  Bioorg Chem       Date:  2020-05-16       Impact factor: 5.275

Review 6.  Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents.

Authors:  Austin Horton; Isaac T Schiefer
Journal:  Nitric Oxide       Date:  2019-01-11       Impact factor: 4.427

7.  A 1,536-well-based kinetic HTS assay for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.

Authors:  Wendy A Lea; Ajit Jadhav; Ganesha Rai; Ahmed A Sayed; Cynthia L Cass; James Inglese; David L Williams; Christopher P Austin; Anton Simeonov
Journal:  Assay Drug Dev Technol       Date:  2008-08       Impact factor: 1.738

8.  Identification of oxadiazoles as new drug leads for the control of schistosomiasis.

Authors:  Ahmed A Sayed; Anton Simeonov; Craig J Thomas; James Inglese; Christopher P Austin; David L Williams
Journal:  Nat Med       Date:  2008-03-16       Impact factor: 53.440

9.  Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives.

Authors:  H Kankaanranta; E Rydell; A S Petersson; P Holm; E Moilanen; T Corell; G Karup; P Vuorinen; S B Pedersen; A Wennmalm; T Metsä-Ketelä
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.

Authors:  Ganesha Rai; Ahmed A Sayed; Wendy A Lea; Hans F Luecke; Harinath Chakrapani; Stefanie Prast-Nielsen; Ajit Jadhav; William Leister; Min Shen; James Inglese; Christopher P Austin; Larry Keefer; Elias S J Arnér; Anton Simeonov; David J Maloney; David L Williams; Craig J Thomas
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.